Pharmacotherapy for social anxiety disorder: an update.

Article Details

Citation

Van Ameringen M, Mancini C, Patterson B, Simpson W

Pharmacotherapy for social anxiety disorder: an update.

Isr J Psychiatry Relat Sci. 2009;46(1):53-61.

PubMed ID
19728573 [ View in PubMed
]
Abstract

Since the emergence of social phobia into the diagnostic nomenclature, we have seen an exponential expansion in our knowledge regarding effective treatment of this disorder. The literature clearly supports the use of SSRIs and the SNRI venlafaxine ER as first line pharmacological agents in the treatment of GSAD. In this article, treatment studies of pharmacotherapy of social phobia are summarized. Additional issues such as comparative efficacy, treatment resistance and relapse-prevention are reviewed.

DrugBank Data that Cites this Article

Drug Targets
DrugTargetKindOrganismPharmacological ActionActions
VenlafaxineSodium-dependent noradrenaline transporterProteinHumans
Yes
Inhibitor
Details
VenlafaxineSodium-dependent serotonin transporterProteinHumans
Yes
Inhibitor
Details